Cogent Biosciences, Inc. COGT Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s change in other liabilities?
- Cogent Biosciences, Inc. (COGT) reported change in other liabilities of $29K in Q1 2026.
- How has Cogent Biosciences, Inc.'s change in other liabilities changed year-over-year?
- Cogent Biosciences, Inc.'s change in other liabilities increased by 480.0% year-over-year, from $5K to $29K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.